Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Asher

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzeesJ Goudsmit, C Debouck, R H Meloen, et al.
Journal of Medical Virology|December 1, 1988
Antibodies to HTLV-I in populations of the southwestern PacificD M Asher, J Goudsmit, K L Pomeroy, et al.
Journal of Medical Virology|April 1, 1990
Detection of measles virus genomic sequences in SSPE brain tissue by the polymerase chain reactionM S Godec, D M Asher, P T Swoveland, et al.
Journal of Virology|October 1, 1987
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated virusesP L Nara, W G Robey, L O Arthur, et al.
Archives of General Psychiatry|July 1, 1988
Intracerebral inoculation of experimental animals with brain tissue from patients with schizophrenia. Failure to observe consistent or specific behavioral and neuropathological effectsC A Kaufmann, D R Weinberger, J R Stevens, et al.
Schizophrenia Bulletin|January 1, 1988
Genetics, immunology, and virologyL Eaves, S C Schulz, M Sharp, et al.
The Journal of Infectious Diseases|February 1, 1997
Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challengeR E Taffs, Y V Chernokhvostova, E M Dragunsky, et al.
Bulletin of the World Health Organization|July 31, 1999
Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccineR E Taffs, J C Enterline, K Rusmil, et al.
Experimental Neurology|June 1, 1990
Creutzfeldt-Jakob disease and kuru patients lack a mutation consistently found in the Gerstmann-Sträussler-Scheinker syndromeL G Goldfarb, P Brown, D Goldgaber, et al.
Archives of Virology|January 1, 1987
Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculationP L Nara, W G Robey, L O Arthur, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzeesJ Goudsmit, C Debouck, R H Meloen, et al.
Journal of Medical Virology|December 1, 1988
Antibodies to HTLV-I in populations of the southwestern PacificD M Asher, J Goudsmit, K L Pomeroy, et al.
Journal of Medical Virology|April 1, 1990
Detection of measles virus genomic sequences in SSPE brain tissue by the polymerase chain reactionM S Godec, D M Asher, P T Swoveland, et al.
Journal of Virology|October 1, 1987
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated virusesP L Nara, W G Robey, L O Arthur, et al.
Archives of General Psychiatry|July 1, 1988
Intracerebral inoculation of experimental animals with brain tissue from patients with schizophrenia. Failure to observe consistent or specific behavioral and neuropathological effectsC A Kaufmann, D R Weinberger, J R Stevens, et al.
Schizophrenia Bulletin|January 1, 1988
Genetics, immunology, and virologyL Eaves, S C Schulz, M Sharp, et al.
The Journal of Infectious Diseases|February 1, 1997
Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challengeR E Taffs, Y V Chernokhvostova, E M Dragunsky, et al.
Bulletin of the World Health Organization|July 31, 1999
Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccineR E Taffs, J C Enterline, K Rusmil, et al.
Experimental Neurology|June 1, 1990
Creutzfeldt-Jakob disease and kuru patients lack a mutation consistently found in the Gerstmann-Sträussler-Scheinker syndromeL G Goldfarb, P Brown, D Goldgaber, et al.
Archives of Virology|January 1, 1987
Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculationP L Nara, W G Robey, L O Arthur, et al.
Pageof 9